Примери за използване на See also information на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
See also information under the heading“Do not take Tolucombi”.
ACE-inhibitors or aliskiren see also information under the headings“Do not take Twynsta” and.
See also information under the heading“Do not take CoAprovel”.
MabCampath is administered into one of your veins via a drip see also‘information intended for.
See also information under the heading“Do not take Dafiro HCT”.
The lines from the drip bag are then connected directly into one of your veins(see also‘ information intended for medical or healthcare professionals').
See also information under the heading“Do not take Telmisartan Teva”.
If you are taking an ACE-inhibitor or aliskiren(see also information under the headings“Do not take Karvea” and“Warnings and precautions”).
See also information under the heading“Do not< take>< use> X””.
If you are taking an ACE-inhibitor or aliskiren(see also information under the headings“Do not take Actelsar HCT” and“Warnings and precautions”).
See also information under the heading“Do not take Irbesartan Zentiva”.
If you are taking an ACE-inhibitor or aliskiren(see also information under the headings“Do not< take>< use> X” and“Warnings and precautions”).
See also information under the heading“Do not take Telmisartan Actavis”.
If you are taking an ACE-inhibitor or aliskiren(see also information under the headings“Do not take Telmisartan Teva Pharma” and“Warnings and precautions”).
See also information under the heading“Do not take Amlodipine/Valsartan Mylan”.
Your doctor may need to change your dose and/or to take other precautions if you are taking an ACE-inhibitor or aliskiren(see also information under the headings“Do not take Edarbi” and“Warnings and precautions”).
See also information on clinical benefit and tolerability in sections 4.4, 4.8 and.
If you are taking an angiotensin II receptor blocker(ARB)or an ACE-inhibitor,(see also information under the headings“Do not< take>< use> X” and“Warnings and precautions”)”.
See also information on clinical benefit and tolerability in sections 4.4, 4.8 and 5.1.
Your doctor may need to change your dose and/or to take other precautions: If you are taking an angiotensin II receptor blocker(ARB)or aliskiren(see also information under the headings“Do not< take>< use> X” and“Warnings and precautions”)”.
See also information on previous and concomitant use of systemic aminoglycosides and diuretics in section 4.4.
Your doctor may need to change your dose and/or to take other precautions:- If you are taking an ACE-inhibitor or aliskiren(see also information under the headings“Do not take Ifirmasta” and“Warnings and precautions”).
ACE inhibitors or aliskiren-(see also information under the headings“Do not take Dafiro HCT” and“Warnings and precautions”).
See also Information intended for medical or healthcare professionals for deltoid injection needle selection based on body weight.
ACE inhibitors or aliskiren( see also information under the headings“ Do not take Amlodipine/ Valsartan Mylan” and“ Warnings and precautions”); diuretics( a type of medicine also called“ water tablets” which increases the amount of urine you produce); lithium( a medicine used to treat some types of depression); potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels; certain types of painkillers called non-steroidal anti-inflammatory medicines( NSAIDs) or selective cyclooxygenase-2 inhibitors( COX-2 inhibitors).
See also general information on induction above regarding time courses of the interaction.
See also further information in this section under“Warnings and precautions” and“Pregnancy and breast-feeding”.
Efficacy/safety data is insufficient to establish a relation between exposure and response(see also paediatric information in section 4.2).
You see, food is also information.